Navigation Links
Cervical Cancer Can Now Be Better Handled With Gene Silencing Therapy

Queensland University researchers have ventured into a new approach called ‘gene silencing’ for the treatment of cervical cancer. The technique is targeted towards turning // the cancer causing genes on and off to help cervical cancer patients.

Certain genes called tumor suppressor genes are responsible for preventing the occurrence of a particular type of cancer. On the other hand, tumor-promoting genes help in the initiation and progression of tumor. A logical way to combat tumor is to either turn on the tumor suppressor genes or turn off the tumor promoting genes.

Cervical cancer is the leading cause of cancer death in women aged 25-50 worldwide. Infection with the human papilloma virus is regarded to be a causative factor in cervical cancer as it results in the over-production of two viral cancer-causing genes called E6 and E7.

The researchers were successful in killing the cervical cancer cells by turning of the production of these genes in cancer cells. Furthermore, gene silencing was found to enhance the effect of chemotherapy by up to four times.

One main advantage of this approach is that the normal cells remain unaffected during manipulation, as the main target is the viral gene. The researchers hope to exploit this form of treatment to all forms of cervical cancer including the premalignant lesions picked up by the pap smear and especially for advanced cervical cancers where the cancer has moved to other sites such as the lung or liver.

The current results have been demonstrated in cervical cancer cell lines grown in test tubes. The next step is to achieve the same desired effect in animal models. If successful, the next stage of research will focus on the development of materials for human trials to allow proper delivery of the drug to patients and to investigate whether other cancer types can be treated this way.

Although the trials are under an experimental phase, if successful, it can turn out to be an advanced form of the currently existing treatment options such as surgery, radiotherapy and chemotherapy. At the least, a cancer-specific treatment for advanced cervical cancers would be arrived at either alone or in combination with existing treatments.

'"/>




Related medicine news :

1. Virus Level could Predict Cervical Cancer Risk
2. Smallpox Vaccine May Help Fight Cervical Cancer
3. Obesity Increases Risk of Cervical Cancer
4. Reducing The Risk Of Cervical Cancer
5. Improving Fertility In Patients With Cervical Cancer
6. Vaccine for Cervical cancer
7. Cervical spinal injury patients may have more damage left undetected
8. Cervical Cancer Vaccine To Be Developed In India
9. Cervical Cancer Recurrence Risk Even After Removal Of Pre-Cancerous Cells
10. HPV Vaccines for Cervical Cancer
11. Vaccine For Cervical Cancer Awaits Approval
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/27/2017)... MD (PRWEB) , ... July 27, 2017 , ... ... Teams of entrepreneurs will compete to form startup companies around 117 breakthrough inventions ... Heart, Lung, and Blood Institute, and National Institute of Biomedical Imaging and Bioengineering), ...
(Date:7/27/2017)... ... July 27, 2017 , ... Cremations recently surpassed traditional burials ... Association, this trend is expected to continue with over 70% of Americans projected to ... demand for new innovations that enable families to celebrate the life of a lost ...
(Date:7/26/2017)... ... 2017 , ... An inventor from Salisbury, N.C., knows the difficulties involved with ... and dignified way to keep leeches in place during therapy," she said. "That’s why ... an effective way to keep a leech in place on the skin during therapy. ...
(Date:7/26/2017)... ... July 26, 2017 , ... Written By: ... a major advancement in drug therapy for patients living with relapsing and primary ... a novel B cell targeted therapy that has been proven to significantly reduce ...
(Date:7/26/2017)... , ... July 26, 2017 , ... ... Management Solutions as part of their continued efforts to provide innovative offerings to ... the best IT resources and build dynamic, high-performing teams to address healthcare IT’s ...
Breaking Medicine News(10 mins):
(Date:7/20/2017)... -- Prime Therapeutics LLC (Prime) released this statement from its Chief ... for Clinical and Economic Review,s (ICER) public meeting ... of abuse-deterrent formulations (ADF) of opioids. Prime was the sole ... "The ICER data ... use of abuse-deterrent formulations (ADF) in opioids in terms of ...
(Date:7/14/2017)... 14, 2017 Endo International plc (NASDAQ: ENDP ... 8, 2017.  Members of its senior management team will host a ... 8:30 a.m. ET. The dial-in number to access ... (678) 509-7598, and the passcode is 45397076. Please dial in 10 ... A replay of the call will be available ...
(Date:7/13/2017)...  New York City-based market research firm Kalorama Information notes ... of.  From new products to new costs, to the threat ... completed study, Potential Pipeline Disruptors . Among ... 1.  Age-Driven Growth - True Impact Moment Arriving   ... impact the growing population and, to a more extreme extent, ...
Breaking Medicine Technology: